Phase I/II trial of paclitaxel by 1-hour
โ
John D. Hainsworth; Howard A. Burris III; Joan B. Erland; Lisa H. Morrissey; Ant
๐
Article
๐
1999
๐
John Wiley and Sons
๐
English
โ 84 KB
๐ 2 views
## BACKGROUND. The combination of paclitaxel and carboplatin is widely used in the treatment of patients with advanced nonsmall cell lung carcinoma. In this Phase I/II study the authors evaluated the feasibility, toxicity, and efficacy of adding a third active antineoplastic agent, gemcitabine, to